Brd4 and HEXIM1: Multiple roles in P-TEFb regulation and cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Ruichuan ^a   Yik, Jasper H N ^b   Lew, Qiao Jing ^c   Chao, Sheng Hao ^c,d  

^a XIAMEN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN CONTAINING PROTEIN 4; CYCLIN D1; CYCLIN T1; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; ETOPOSIDE; FLAVOPIRIDOL; HEXAMETHYLENE BISACETAMIDE INDUCIBLE PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NUCLEOPHOSMIN; NUTLIN 3; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN 14 3 3; PROTEIN MDM2; PROTEIN P53; REGULATOR PROTEIN; ROSCOVITINE; SCAFFOLD PROTEIN; SMALL NUCLEAR RNA; TAMOXIFEN; TAMOXIFEN CITRATE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; BINDING SITE; BREAST CANCER; BURKITT LYMPHOMA; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLON CANCER; DAUGHTER CELL; DNA DAMAGE; EPITHELIAL MESENCHYMAL TRANSITION; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; INFLAMMATION; MELANOMA; METASTASIS; MITOSIS; MULTIPLE MYELOMA; NEOPLASM; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 84896808244     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/232870     Document Type: Review

References (129)

1. Marshall N. F., Price D. H., Purification of P-TEFb, a transcription factor required for the transition into productive elongation. The Journal of Biological Chemistry 1995 270 21 12335 12338 2-s2.0-0029011873 10.1074/jbc.270.21.12335
2. Henriques T., Gilchrist D. A., Nechaev S., Bern M., Muse G. W., Burkholder A., Fargo D. C., Adelman K., Stable pausing by RNA polymerase II provides an opportunity to target and integrate regulatory signals. Molecular Cell 2013 52 4 517 528
3. Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa H., Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. The EMBO Journal 1998 17 24 7395 7403 2-s2.0-0032534814 10.1093/emboj/17.24.7395
4. Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., Hasegawa J., Handa H., NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 1999 97 1 41 51 2-s2.0-0033515521
5. Cheng B., Li T., Rahl P. B., Adamson T. E., Loudas N. B., Guo J., Varzavand K., Cooper J. J., Hu X., Gnatt A., Young R. A., Price D. H., Functional association of gdown1 with RNA polymerase II poised on human genes. Molecular Cell 2012 45 1 38 50 2-s2.0-84855896565 10.1016/j.molcel.2011.10.022
6. Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B. M., Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Molecular and Cellular Biology 2004 24 2 787 795 2-s2.0-0346095303 10.1128/MCB.24.2.787-795.2004
7. Ivanov D., Kwak Y. T., Guo J., Gaynor R. B., Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Molecular and Cellular Biology 2000 20 9 2970 2983 2-s2.0-0342748478 10.1128/MCB.20.9.2970-2983.2000
8. Hargreaves D. C., Horng T., Medzhitov R., Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009 138 1 129 145 2-s2.0-67649648237 10.1016/j.cell.2009.05.047
9. Zippo A., Serafini R., Rocchigiani M., Pennacchini S., Krepelova A., Oliviero S., Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009 138 6 1122 1136 2-s2.0-70149112313 10.1016/j.cell.2009.07.031
10. Chao S.-H., Fujinaga K., Marion J. E., Taube R., Sausville E. A., Senderowicz A. M., Peterlin B. M., Price D. H., Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. The Journal of Biological Chemistry 2000 275 37 28345 28348 2-s2.0-0034665961
11. Chao S.-H., Price D. H., Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. The Journal of Biological Chemistry 2001 276 34 31793 31799 2-s2.0-0035943710 10.1074/jbc.M102306200
12. Guenther M. G., Levine S. S., Boyer L. A., Jaenisch R., Young R. A., A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007 130 1 77 88 2-s2.0-34447098370 10.1016/j.cell.2007.05.042
13. Zeitlinger J., Stark A., Kellis M., Hong J.-W., Nechaev S., Adelman K., Levine M., Young R. A., RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nature Genetics 2007 39 12 1512 1516 2-s2.0-36549013619 10.1038/ng.2007.26
14. Muse G. W., Gilchrist D. A., Nechaev S., Shah R., Parker J. S., Grissom S. F., Zeitlinger J., Adelman K., RNA polymerase is poised for activation across the genome. Nature Genetics 2007 39 12 1507 1511 2-s2.0-36549061004 10.1038/ng.2007.21
15. Kwak H., Fuda N. J., Core L. J., Lis J. T., Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 2013 339 6122 950 953
16. Core L. J., Waterfall J. J., Gilchrist D. A., Fargo D. C., Kwak H., Adelman K., Lis J. T., Defining the status of RNA polymerase at promoters. Cell Reports 2012 2 4 1025 1035
17. Laspia M. F., Rice A. P., Mathews M. B., HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 1989 59 2 283 292 2-s2.0-0024414213
18. Wimmer J., Fujinaga K., Taube R., Cujec T. P., Zhu Y., Peng J., Price D. H., Peterlin B. M., Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology 1999 255 1 182 189 2-s2.0-0033102387 10.1006/viro.1998.9589
19. Garber M. E., Wei P., KewalRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A., The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes and Development 1998 12 22 3512 3527 2-s2.0-0032533253
20. Chen D., Fong Y., Zhou Q., Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2728 2733 2-s2.0-0033053040 10.1073/pnas.96.6.2728
21. Peng J., Marshall N. F., Price D. H., Identification of a cyclin subunit required for the function of Drosophila P-TEFb. The Journal of Biological Chemistry 1998 273 22 13855 13860 2-s2.0-0032577577 10.1074/jbc.273.22.13855
22. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A., A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998 92 4 451 462 2-s2.0-0032548918 10.1016/S0092-8674(00)80939-3
23. Shim E. Y., Walker A. K., Shi Y., Blackwell T. K., CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes and Development 2002 16 16 2135 2146 2-s2.0-0037102566 10.1101/gad.999002
24. Ni Z., Schwartz B. E., Werner J., Suarez J.-R., Lis J. T., Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Molecular Cell 2004 13 1 55 65 2-s2.0-1642441939 10.1016/S1097-2765(03)00526-4
25. Bartkowiak B., Liu P., Phatnani H. P., Fuda N. J., Cooper J. J., Price D. H., Adelman K., Lis J. T., Greenleaf A. L., CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes and Development 2010 24 20 2303 2316 2-s2.0-77958587420 10.1101/gad.1968210
26. Shore S. M., Byers S. A., Maury W., Price D. H., Identification of a novel isoform of Cdk9. Gene 2003 307 1-2 175 182 2-s2.0-0037468903 10.1016/S0378-1119(03)00466-9
27. Peng J., Zhu Y., Milton J. T., Price D. H., Identification of multiple cyclin subunits of human P-TEFb. Genes and Development 1998 12 5 755 762 2-s2.0-0032031706
28. Fu T.-J., Peng J., Lee G., Price D. H., Flores O., Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. The Journal of Biological Chemistry 1999 274 49 34527 34530 2-s2.0-0033521094 10.1074/jbc.274.49.34527
29. Yik J. H. N., Chen R., Nishimura R., Jennings J. L., Link A. J., Zhou Q., Inhibition of P-TEFb (CDK9/cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Molecular Cell 2003 12 4 971 982 2-s2.0-0242361319 10.1016/S1097-2765(03)00388-5
30. Michels A. A., Nguyen V. T., Fraldi A., Labas V., Edwards M., Bonnet F., Lania L., Bensaude O., MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Molecular and Cellular Biology 2003 23 14 4859 4869 2-s2.0-0038111978 10.1128/MCB.23.14.4859-4869.2003
31. Jeronimo C., Forget D., Bouchard A., Li Q., Chua G., Poitras C., Thérien C., Bergeron D., Bourassa S., Greenblatt J., Chabot B., Poirier G. G., Hughes T. R., Blanchette M., Price D. H., Coulombe B., Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Molecular Cell 2007 27 2 262 274 2-s2.0-34447321025 10.1016/j.molcel.2007.06.027
32. Krueger B. J., Jeronimo C., Roy B. B., Bouchard A., Barrandon C., Byers S. A., Searcey C. E., Cooper J. J., Bensaude O., Cohen É. A., Coulombe B., Price D. H., LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Research 2008 36 7 2219 2229 2-s2.0-42449086866 10.1093/nar/gkn061
33. Michels A. A., Fraldi A., Li Q., Adamson T. E., Bonnet F., Nguyen V. T., Sedore S. C., Price J. P., Price D. H., Lania L., Bensaude O., Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. The EMBO Journal 2004 23 13 2608 2619 2-s2.0-3342967685 10.1038/sj.emboj.7600275
34. Barboric M., Kohoutek J., Price J. P., Blazek D., Price D. H., Peterlin B. M., Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb. The EMBO Journal 2005 24 24 4291 4303 2-s2.0-29244474416 10.1038/sj.emboj.7600883
35. Yang Z., Yik J. H. N., Chen R., He N., Moon K. J., Ozato K., Zhou Q., Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Molecular Cell 2005 19 4 535 545 2-s2.0-23744467035 10.1016/j.molcel.2005.06.029
36. Jang M. K., Mochizuki K., Zhou M., Jeong H.-S., Brady J. N., Ozato K., The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Molecular Cell 2005 19 4 523 534 2-s2.0-23744514308 10.1016/j.molcel.2005.06.027
37. Zhou Q., Yik J. H. N., The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiology and Molecular Biology Reviews 2006 70 3 646 659 2-s2.0-33749234198 10.1128/MMBR.00011-06
38. Dey A., Chao S.-H., Lane D. P., HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy. Cell Cycle 2007 6 15 1856 1863 2-s2.0-34548219126
39. Strahl B. D., Allis C. D., The language of covalent histone modifications. Nature 2000 403 6765 41 45 2-s2.0-0034610814 10.1038/47412
40. Sanchez R., Zhou M.-M., The role of human bromodomains in chromatin biology and gene transcription. Current Opinion in Drug Discovery and Development 2009 12 5 659 665 2-s2.0-70149105669
41. Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.-P., Barsyte-Lovejoy D., Felletar I., Volkmer R., Müller S., Pawson T., Gingras A.-C., Arrowsmith C. H., Knapp S., Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012 149 1 214 231 2-s2.0-84859181036 10.1016/j.cell.2012.02.013
42. Muller S., Filippakopoulos P., Knapp S., Bromodomains as therapeutic targets. Expert Reviews in Molecular Medicine 2011 13 e29 2-s2.0-84856394571
43. Chiang C. M., Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biology Reports 2009 1 98
44. Rahman S., Sowa M. E., Ottinger M., Smith J. A., Shi Y., Harper J. W., Howley P. M., The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Molecular and Cellular Biology 2011 31 13 2641 2652 2-s2.0-79959483607 10.1128/MCB.01341-10
45. Dey A., Chitsaz F., Abbasi A., Misteli T., Ozato K., The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 15 8758 8763 2-s2.0-0041806599 10.1073/pnas.1433065100
46. Dey A., Ellenberg J., Farina A., Coleman A. E., Maruyama T., Sciortino S., Lippincott-Schwartz J., Ozato K., A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition. Molecular and Cellular Biology 2000 20 17 6537 6549 2-s2.0-0033842522 10.1128/MCB.20.17.6537-6549.2000
47. Mochizuki K., Nishiyama A., Jang M. K., Dey A., Ghosh A., Tamura T., Natsume H., Yao H., Ozato K., The bromodomain protein Brd4 stimulates g1 gene transcription and promotes progression to S phase. The Journal of Biological Chemistry 2008 283 14 9040 9048 2-s2.0-42049095157 10.1074/jbc.M707603200
48. Yang Z., He N., Zhou Q., Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G 1 gene expression and cell cycle progression. Molecular and Cellular Biology 2008 28 3 967 976 2-s2.0-38549113034 10.1128/MCB.01020-07
49. Dey A., Nishiyama A., Karpova T., McNally J., Ozato K., Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Molecular Biology of the Cell 2009 20 23 4899 4909 2-s2.0-73949087197 10.1091/mbc.E09-05- 0380
50. Zhao R., Nakamura T., Fu Y., Lazar Z., Spector D. L., Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nature Cell Biology 2011 13 11 1295 1304 2-s2.0-80455122751 10.1038/ncb2341
51. Devaiah B. N., Singer D. S., Two faces of BRD4: mitotic bookmark and transcriptional lynchpin. Transcription 2012 4 1 13 17
52. Voigt P., Reinberg D., BRD4 jump-starts transcription after mitotic silencing. Genome Biology 2011 12 11, article 133 2-s2.0-82255175234 10.1186/gb-2011-12-11-133
53. Wang R., Li Q., Helfer C. M., Jiao J., You J., Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure. The Journal of Biological Chemistry 2012 287 14 10738 10752 2-s2.0-84859479811 10.1074/jbc.M111.323493
54. You J., Croyle J. L., Nishimura A., Ozato K., Howley P. M., Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004 117 3 349 360 2-s2.0-2042468820 10.1016/S0092-8674(04)00402-7
55. Bisgrove D. A., Mahmoudi T., Henklein P., Verdin E., Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13690 13695 2-s2.0-35348816030 10.1073/pnas.0705053104
56. Nechaev S., Adelman K., Pol II waiting in the starting gates: regulating the transition from transcription initiation into productive elongation. Biochimica et Biophysica Acta 2011 1809 1 34 45 2-s2.0-78650566210 10.1016/j.bbagrm.2010.11.001
57. Zhou Q., Li T., Price D. H., RNA polymerase II elongation control. Annual Review of Biochemistry 2012 81 119 143
58. Guo J., Price D. H., RNA polymerase II transcription elongation control. Chemical Reviews 2013 113 11 8583 8603
59. Diribarne G., Bensaude O., 7SK RNA, a non-coding RNA regulating P-TEFb, a general transcription factor. RNA Biology 2009 6 2 122 128 2-s2.0-66449089824 10.4161/rna.6.2.8115
60. Xue Y., Yang Z., Chen R., Zhou Q., A capping-independent function of MePCE in stabilizing 7SK snRNA and facilitating the assembly of 7SK snRNP. Nucleic Acids Research 2009 38 2 360 369 2-s2.0-77449119756 10.1093/nar/gkp977
61. Chen R., Liu M., Li H., Xue Y., Ramey W. N., He N., Ai N., Luo H., Zhu Y., Zhou N., Zhou Q., PP2B and PP1 α cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling. Genes and Development 2008 22 10 1356 1368 2-s2.0-44149117974 10.1101/gad.1636008
62. Contreras X., Barboric M., Lenasi T., Peterlin B. M., HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathogens 2007 3 10 1459 1469 2-s2.0-36048945927 10.1371/journal.ppat. 0030146
63. Fujinaga K., Barboric M., Li Q., Luo Z., Price D. H., Peterlin B. M., PKC phosphorylates HEXIM1 and regulates P-TEFb activity. Nucleic Acids Research 2012 40 18 9160 9170
64. Ai N., Hu X., Ding F., Yu B., Wang H., Lu X., Zhang K., Li Y., Han A., Lin W., Liu R., Chen R., Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation. Nucleic Acids Research 2011 39 22 9592 9604 2-s2.0-83755220044 10.1093/nar/gkr698
65. Gupta S. S., Maetzig T., Maertens G. N., Sharif A., Rothe M., Weidner-Glunde M., Galla M., Schambach A., Cherepanov P., Schulz T. F., Bromo and ET domain (BET) chromatin regulators serve as co-factors for murine leukemia virus integration. Journal of Virology 2013 10.1128/JVI.01942-13
66. Sharma A., Larue R. C., Plumb M. R., Malani N., Male F., Slaughter A., Kessl J. J., Shkriabai N., Coward E., Aiyer S. S., BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proceedings of the National Academy of Sciences of the United States of America 2013 110 29 12036 12041
67. Margolis D. M., Hazuda D. J., Combined approaches for HIV cure. Current Opinion in HIV and AIDS 2013 8 3 230 235
68. Karn J., A new BET on the control of HIV latency. Cell Cycle 2013 12 4 545 546
69. Zhou M., Huang K., Jung K.-J., Cho W.-K., Klase Z., Kashanchi F., Pise-Masison C. A., Brady J. N., Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. Journal of Virology 2009 83 2 1036 1044 2-s2.0-58149487612 10.1128/JVI.01316-08
70. Chen R., Liu M., Zhang K., Zhou Q., Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation. Methods 2011 53 1 85 90 2-s2.0-78651469063 10.1016/j.ymeth.2010.04.005
71. Zhang G., Liu R., Zhong Y., Plotnikov A. N., Zhang W., Zeng L., Rusinova E., Gerona-Nevarro G., Moshkina N., Joshua J., Down-regulation of NF-kappaB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. The Journal of Biological Chemistry 2012 287 34 28840 28851
72. Huang B., Yang X.-D., Zhou M.-M., Ozato K., Chen L.-F., Brd4 coactivates transcriptional activation of NF- B via specific binding to acetylated RelA. Molecular and Cellular Biology 2009 29 5 1375 1387 2-s2.0-61749088806 10.1128/MCB.01365-08
73. Anand P., Brown J. D., Lin C. Y., Qi J., Zhang R., Artero P. C., Alaiti M. A., Bullard J., Alazem K., Margulies K. B., BET bromodomains mediate transcriptional pause release in heart failure. Cell 2013 154 3 569 582
74. Spiltoir J. I., Stratton M. S., Cavasin M. A., Demos-Davies K., Reid B. G., Qi J., Bradner J. E., McKinsey T. A., BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 2013 63 175 179
75. Floyd S. R., Pacold M. E., Huang Q., Clarke S. M., Lam F. C., Cannell I. G., Bryson B. D., Rameseder J., Lee M. J., Blake E. J., The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature 2013 498 7453 246 250
76. Choi S., Bakkenist C. J., Brd4 shields chromatin from ATM kinase signaling storms. Science Signaling 2013 6 293 pe30
77. Barbieri I., Cannizzaro E., Dawson M. A., Bromodomains as therapeutic targets in cancer. Briefings in Functional Genomics 2013 12 3 219 230
78. Belkina A. C., Denis G. V., BET domain co-regulators in obesity, inflammation and cancer. Nature Reviews Cancer 2012 12 7 465 477
79. French C. A., Miyoshi I., Kubonishi I., Grier H. E., Perez-Atayde A. R., Fletcher J. A., BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Research 2003 63 2 304 307 2-s2.0-0037439788
80. French C. A., Miyoshi I., Aster J. C., Kubonishi I., Kroll T. G., Ci P. D., Vargas S. O., Perez-Atayde A. R., Fletcher J. A., BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). American Journal of Pathology 2001 159 6 1987 1992 2-s2.0-0035180206
81. Polsani A., Braithwaite K. A., Alazraki A. L., Abramowsky C., Shehata B. M., NUT midline carcinoma: an imaging case series and review of literature. Pediatric Radiology 2012 42 2 205 210 2-s2.0-80054873409 10.1007/s00247-011- 2272-3
82. French C. A., Pathogenesis of NUT midline carcinoma. Annual Review of Pathology 2012 7 247 265 2-s2.0-84856857218 10.1146/annurev-pathol-011811-132438
83. French C. A., NUT midline carcinoma. Cancer Genetics and Cytogenetics 2010 203 1 16 20 2-s2.0-78049425945
84. Alsarraj J., Hunter K. W., Bromodomain-Containing protein 4: a dynamic regulator of breast cancer metastasis through modulation of the extracellular matrix. International Journal of Breast Cancer 2012 2012 7 670632 10.1155/2012/670632
85. Alsarraj J., Walker R. C., Webster J. D., Geiger T. R., Crawford N. P. S., Simpson R. M., Ozato K., Hunter K. W., Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to- mesenchymal transition- and stem cell-like conversion. Cancer Research 2011 71 8 3121 3131 2-s2.0-79954603178 10.1158/0008-5472.CAN-10-4417
86. Zou Z., Huang B., Wu X., Zhang H., Qi J., Bradner J., Nair S., Chen L. F., Brd4 maintains constitutively active NF-kappaB in cancer cells by binding to acetylated RelA. Oncogene 2013 10.1038/onc.2013.179
87. Blobel G. A., Kalota A., Sanchez P. V., Carroll M., Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemia. Cancer Cell 2011 20 3 287 288 2-s2.0-80052595172 10.1016/j.ccr.2011.08.019
88. Zuber J., Shi J., Wang E., Rappaport A. R., Herrmann H., Sison E. A., Magoon D., Qi J., Blatt K., Wunderlich M., Taylor M. J., Johns C., Chicas A., Mulloy J. C., Kogan S. C., Brown P., Valent P., Bradner J. E., Lowe S. W., Vakoc C. R., RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011 478 7370 524 528 2-s2.0-80055000824 10.1038/nature10334
89. Dawson M. A., Prinjha R. K., Dittmann A., Giotopoulos G., Bantscheff M., Chan W.-I., Robson S. C., Chung C.-W., Hopf C., Savitski M. M., Huthmacher C., Gudgin E., Lugo D., Beinke S., Chapman T. D., Roberts E. J., Soden P. E., Auger K. R., Mirguet O., Doehner K., Delwel R., Burnett A. K., Jeffrey P., Drewes G., Lee K., Huntly B. J. P., Kouzarides T., Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011 478 7370 529 533 2-s2.0-80054984945 10.1038/nature10509
90. Delmore J. E., Issa G. C., Lemieux M. E., Rahl P. B., Shi J., Jacobs H. M., Kastritis E., Gilpatrick T., Paranal R. M., Qi J., Chesi M., Schinzel A. C., McKeown M. R., Heffernan T. P., Vakoc C. R., Bergsagel P. L., Ghobrial I. M., Richardson P. G., Young R. A., Hahn W. C., Anderson K. C., Kung A. L., Bradner J. E., Mitsiades C. S., BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011 146 6 904 917 2-s2.0-80052955256 10.1016/j.cell.2011.08. 017
91. Mertz J. A., Conery A. R., Bryant B. M., Sandy P., Balasubramanian S., Mele D. A., Bergeron L., Sims R. J. III, Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proceedings of the National Academy of Sciences of the United States of America 2011 108 40 16669 16674 2-s2.0-80053651202 10.1073/pnas.1108190108
92. Segura M. F., Fontanals-Cirera B., Gaziel-Sovran A., Guijarro M. V., Hanniford D., Zhang G., Gonzalez-Gomez P., Morante M., Jubierre L., Zhang W., BRD4 sustains proliferation and represents a new target for epigenetic therapy in melanoma. Cancer Research 2013 73 20 6264 6276
93. Rodriguez R. M., Huidobro C., Urdinguio R. G., Mangas C., Soldevilla B., Domínguez G., Bonilla F., Fernandez A. F., Fraga M. F., Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer. Journal of Molecular Medicine 2012 90 5 587 595 2-s2.0-81855228986 10.1007/s00109-011-0837- 0
94. Loven J., Hoke H. A., Lin C. Y., Lau A., Orlando D. A., Vakoc C. R., Bradner J. E., Lee T. I., Young R. A., Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013 153 2 320 334
95. Khochbin S., When are the BET factors the most sensitive to bromodomain inhibitors? Transcription 2013 4 2 54 57
96. Banerjee T., Chakravarti D., A peek into the complex realm of histone phosphorylation. Molecular and Cellular Biology 2011 31 24 4858 4873 2-s2.0-83255192184 10.1128/MCB.05631-11
97. Nowak S. J., Corces V. G., Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends in Genetics 2004 20 4 214 220 2-s2.0-1642326716 10.1016/j.tig.2004.02.007
98. Rossetto D., Avvakumov N., Cote J., Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 2012 7 10 1098 1108
99. Sawicka A., Seiser C., Histone H3 phosphorylation-a versatile chromatin modification for different occasions. Biochimie 2012 94 11 2193 2201
100. Mahadevan L. C., Willis A. C., Barratt M. J., Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 1991 65 5 775 783 2-s2.0-0025872683
101. Kusuhara M., Nagasaki K., Kimura K., Maass N., Manabe T., Ishikawa S., Aikawa M., Miyazaki K., Yamaguchi K., Cloning of hexamethylene-bis-acetamide- inducible transcript, HEXIM1, in human vascular smooth muscle cells. Biomedical Research 1999 20 5 273 279 2-s2.0-0033501002
102. Ghatpande S., Goswami S., Mathew S., Rong G., Cai L., Shafiq S., Siddiqui M. A. Q., Identification of a novel cardiac lineage-associated protein(cCLP-1): a candidate regulator of cardiogenesis. Developmental Biology 1999 208 1 210 221 2-s2.0-0033120663 10.1006/dbio.1998.9180
103. Lew Q. J., Chu K. L., Chia Y. L., Cheong N., Chao S. H., HEXIM1, a New Player in the p53 Pathway. Cancers 2013 5 838 856
104. Wittmann B. M., Wang N., Montano M. M., Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Research 2003 63 16 5151 5158 2-s2.0-0042014234
105. Castro-Rivera E., Samudio I., Safe S., Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. The Journal of Biological Chemistry 2001 276 33 30853 30861 2-s2.0-0035903160 10.1074/jbc.M103339200
106. Shang Y., Hu X., DiRenzo J., Lazar M. A., Brown M., Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000 103 6 843 852 2-s2.0-0033637703
107. Ali S., Coombes R. C., Estrogen receptor alpha in human breast cancer: occurrence and significance. Journal of Mammary Gland Biology and Neoplasia 2000 5 3 271 281 2-s2.0-0034485142 10.1023/A:1009594727358
108. Katzenellenbogen B. S., Frasor J., Therapeutic Targeting in the Estrogen Receptor Hormonal Pathway. Seminars in Oncology 2004 31 1, supplement 3 28 38 2-s2.0-2142652244
109. Wittmann B. M., Fujinaga K., Deng H., Ogba N., Montano M. M., The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene 2005 24 36 5576 5588 2-s2.0-24644486087 10.1038/sj.onc.1208728
110. Lewis-Wambi J. S., Jordan V. C., Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Disease 2005 24 1 93 105 2-s2.0-33747347877
111. Ketchart W., Ogba N., Kresak A., Albert J. M., Pink J. J., Montano M. M., HEXIM1 is a critical determinant of the response to tamoxifen. Oncogene 2011 30 33 3563 3569 2-s2.0-80051796258 10.1038/onc.2011.76
112. Ferrara N., Gerber H.-P., LeCouter J., The biology of VEGF and its receptors. Nature Medicine 2003 9 6 669 676 2-s2.0-0037699954 10.1038/nm0603-669
113. Ogba N., Doughman Y. Q., Chaplin L. J., Hu Y., Gargesha M., Watanabe M., Montano M. M., HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland. Oncogene 2010 29 25 3639 3649 2-s2.0-77954087427 10.1038/onc.2010.110
114. Yeh I. J., Ogba N., Bensigner H., Welford S. M., Montano M. M., HEXIM1 downregulates Hypoxia Inducible Factor-1 alpha protein stability. Biochemical Journal 2013 456 195 204
115. Folkman J., Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology 2002 29 6, supplement 16 15 18 2-s2.0-0036984640
116. Ketchart W., Smith K. M., Krupka T., Wittmann B. M., Hu Y., Rayman P. A., Doughman Y. Q., Albert J. M., Bai X., Finke J. H., Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene 2013 32 33 3829 3839
117. Gurumurthy M., Tan C. H., Ng R., Zeiger L., Lau J., Lee J., Dey A., Philp R., Li Q., Lim T. M., Price D. H., Lane D. P., Chao S.-H., Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription. Journal of Molecular Biology 2008 378 2 302 317 2-s2.0-41449083855 10.1016/j.jmb.2008.02. 055
118. Colombo E., Marine J.-C., Danovi D., Falini B., Pelicci P. G., Nucleophosmin regulates the stability and transcriptional activity of p53. Nature Cell Biology 2002 4 7 529 533 2-s2.0-0036302062 10.1038/ncb814
119. Weber J. D., Taylor L. J., Roussel M. F., Sherr C. J., Bar-Sagi D., Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biology 1999 1 1 20 26 2-s2.0-0033130010
120. Kamijo T., Zindy F., Roussel M. F., Quelle D. E., Downing J. R., Ashmun R. A., Grosveld G., Sherr C. J., Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19(ARF). Cell 1997 91 5 649 659 2-s2.0-0030728468
121. Kurki S., Peltonen K., Latonen L., Kiviharju T. M., Ojala P. M., Meek D., Laiho M., Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004 5 5 465 475 2-s2.0-2342491487 10.1016/S1535-6108(04)00110-2
122. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P., Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F., Pelicci P.-G., Martelli M. F., Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. The New England Journal of Medicine 2005 352 3 254 266 2-s2.0-19944427850 10.1056/NEJMoa041974
123. Alcalay M., Tiacci E., Bergomas R., Bigerna B., Venturini E., Minardi S. P., Meani N., Diverio D., Bernard L., Tizzoni L., Volorio S., Luzi L., Colombo E., Lo Coco F., Mecucci C., Falini B., Pelicci P. G., Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005 106 3 899 902 2-s2.0-23044459136 10.1182/blood-2005-02- 0560
124. Lew Q. J., Tan C. H., Gurumurthy M., Chu K. L., Cheong N., Lane D. P., Chao S.-H., NPMc+ AML cell line shows differential protein expression and lower sensitivity to DNA-damaging and p53-inducing anti-cancer compounds. Cell Cycle 2011 10 12 1978 1987 2-s2.0-79959223906 10.4161/cc.10.12.15859
125. Levine A. J., p53, the cellular gatekeeper for growth and division. Cell 1997 88 3 323 331 2-s2.0-0030941458 10.1016/S0092-8674(00)81871-1
126. Honda R., Tanaka H., Yasuda H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters 1997 420 1 25 27 2-s2.0-0031583962 10.1016/S0014-5793(97)01480-4
127. Rodriguez M. S., Desterro J. M. P., Lain S., Lane D. P., Hay R. T., Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Molecular and Cellular Biology 2000 20 22 8458 8467 2-s2.0-0033767235 10.1128/MCB.20.22.8458-8467.2000
128. Lau J., Lew Q. J., Diribarne G., Michels A. A., Dey A., Bensaude O., Lane D. P., Chao S.-H., Ubiquitination of HEXIM1 by HDM2. Cell Cycle 2009 8 14 2247 2254 2-s2.0-68049106187
129. Lew Q. J., Chia Y. L., Chu K. L., Lam Y. T., Gurumurthy M., Xu S., Lam K. P., Cheong N., Chao: S. H., Identification of HEXIM1 as a positive regulator of p53. The Journal of Biological Chemistry 2012 287 43 36443 36454